These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15670046)

  • 41. Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A₂ receptor antagonists.
    Bambi-Nyanguile SM; Hanson J; Ooms A; Alpan L; Kolh P; Dogné JM; Pirotte B
    Eur J Med Chem; 2013 Jul; 65():32-40. PubMed ID: 23688698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From the design to the clinical application of thromboxane modulators.
    Dogné JM; Hanson J; de Leval X; Pratico D; Pace-Asciak CR; Drion P; Pirotte B; Ruan KH
    Curr Pharm Des; 2006; 12(8):903-23. PubMed ID: 16533159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function.
    Dogné JM; de Leval X; Kolh P; Sanna V; Rolin S; Michaux C; Mauer M; David JL; Masereel B; Pirotte B
    Prostaglandins Leukot Essent Fatty Acids; 2003 Jan; 68(1):49-54. PubMed ID: 12538090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor.
    Huang RY; Li MY; Hsin MK; Underwood MJ; Ma LT; Mok TS; Warner TD; Chen GG
    Oncogene; 2011 Jan; 30(1):106-16. PubMed ID: 20818420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of dual-acting benzofurans for thromboxane A2 receptor antagonist and prostacyclin receptor agonist: synthesis, structure-activity relationship, and evaluation of benzofuran derivatives.
    Ohno M; Miyamoto M; Hoshi K; Takeda T; Yamada N; Ohtake A
    J Med Chem; 2005 Aug; 48(16):5279-94. PubMed ID: 16078846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression by beta-lactam antibiotics of thromboxane A2 generation and arachidonic acid release in rabbit platelets in vitro.
    Mihara S; Fujimoto M; Okabayashi T
    Thromb Res; 1986 Nov; 44(3):265-75. PubMed ID: 3798399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamic interplay of the P2Y(1), P2Y(12), and TxA(2) pathways in platelets: the potential of triple antiplatelet therapy with P2Y(1) receptor antagonism.
    Oestreich JH; Ferraris SP; Steinhubl SR; Akers WS
    Thromb Res; 2013 Feb; 131(2):e64-70. PubMed ID: 23245937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity.
    Jin YR; Han XH; Zhang YH; Lee JJ; Lim Y; Chung JH; Yun YP
    Atherosclerosis; 2007 Sep; 194(1):144-52. PubMed ID: 17092506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
    Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
    Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Castration reduces platelet thromboxane A2 receptor density and aggregability.
    Ajayi AA; Halushka PV
    QJM; 2005 May; 98(5):349-56. PubMed ID: 15820970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors.
    Baldassarri S; Bertoni A; Bagarotti A; Sarasso C; Zanfa M; Catani MV; Avigliano L; Maccarrone M; Torti M; Sinigaglia F
    J Thromb Haemost; 2008 Oct; 6(10):1772-9. PubMed ID: 18647220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effect of ethanol extract of Piper longum L. on rabbit platelet aggregation through antagonizing thromboxane A2 receptor.
    Iwashita M; Saito M; Yamaguchi Y; Takagaki R; Nakahata N
    Biol Pharm Bull; 2007 Jul; 30(7):1221-5. PubMed ID: 17603157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and in vitro platelet aggregation and TP receptor binding studies on bicyclic 5,8-ethanooctahydroisoquinolines and 5,8-ethanotetrahydroisoquinolines.
    Saha SL; Roche VF; Pendola K; Kearley M; Lei L; Romstedt KJ; Herdman M; Shams G; Kaisare V; Feller DR
    Bioorg Med Chem; 2002 Aug; 10(8):2779-93. PubMed ID: 12057668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic analogues of flavonoids with improved activity against platelet activation and aggregation as novel prototypes of food supplements.
    Del Turco S; Sartini S; Cigni G; Sentieri C; Sbrana S; Battaglia D; Papa A; Da Settimo F; La Motta C; Basta G
    Food Chem; 2015 May; 175():494-9. PubMed ID: 25577111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
    Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.